Rituximab as a therapeutic consideration for refractory eosinophilic fasciitis

Authors

Amanda F. Nahhas, Henry Ford Health
Mohsin Alam, Henry Ford HealthFollow
Henry W. Lim, Henry Ford HealthFollow

Recommended Citation

Nahhas AF, Alam M, Lim HW. Rituximab as a therapeutic consideration for refractory eosinophilic fasciitis. Int J Dermatol. 2018 May;57(5):614-615.

Document Type

Article

Publication Date

5-1-2018

Publication Title

International journal of dermatology

Medical Subject Headings

Administration, Oral; Adrenal Cortex Hormones; Aged; Arm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Eosinophilia; Fasciitis; Follow-Up Studies; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methotrexate; Recurrence; Rituximab; Severity of Illness Index; Treatment Outcome

PubMed ID

29446454

Volume

57

Issue

5

First Page

614

Last Page

615